Adiponectin and insulin cross talk: the microvascular connection
Lina Zhao1, Zhuo Fu1, Zhenqi Liu1
1Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia Health System, PO Box 801410, Charlottesville, VA 22908.
Trends in Cardiovascular Medicine
|September 16, 2014
Summary
Adiponectin improves insulin sensitivity by enhancing muscle microvasculature function. This increases insulin delivery to muscle cells, a key mechanism for its beneficial effects.
Area of Science:
- Endocrinology
- Metabolism
- Vascular Biology
Background:
- Adiponectin, a hormone, has vasodilatory and insulin-sensitizing properties.
- Lower adiponectin levels are observed in insulin resistance.
- Mechanisms of adiponectin's insulin-sensitizing effects are not fully understood.
Purpose of the Study:
- To review the role of muscle microvasculature in adiponectin's insulin-sensitizing action.
- To elucidate the connection between adiponectin, microvasculature, and insulin signaling.
Main Methods:
- Review of existing literature on adiponectin and microvascular function.
- Focus on the interplay between adiponectin and muscle insulin delivery.
Main Results:
- Adiponectin enhances insulin sensitivity by recruiting muscle microvasculature.
- It expands endothelial surface area, improving insulin delivery to muscle.
- This microvascular recruitment is a key pathway for adiponectin's action.
Conclusions:
- Muscle microvasculature is a critical mediator of adiponectin's insulin-sensitizing effects.
- Adiponectin-microvasculature interaction is central to improving insulin action in muscle.
More Related Videos
Related Concept Videos
01:28Insulin: The Receptor and Signaling Pathways
5.9K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.9K
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.7K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.7K
01:26Type I Diabetes II: Pathophysiology
42
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
42
01:16Hormones Regulating Blood Glucose
7.3K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
7.3K
01:05Insulin Secretory Vesicles
6.2K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.2K
01:24Type II Diabetes II: Pathophysiology
8
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
8